ReviewACS omega2026
Radiopharmaceuticals in Renal Imaging: A Comprehensive Review of Current Applications and Future Prospects.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and characterization of [RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The kidneys play a vital role in filtration, excretion, and metabolic regulation, making accurate functional assessment essential for diagnosis, monitoring, and management of renal diseases. While conventional imaging modalities such as ultrasonography, computed tomography (CT), and multiparametric magnetic resonance imaging (MRI) provide structural and functional information, nuclear medicine techniques enable more detailed evaluation of renal physiology at the molecular level. This review provides a comprehensive overview of functional renal imaging using both conventional renal scintigraphy and emerging positron emission tomography (PET) radiopharmaceuticals. Established renal scintigraphy radiopharmaceuticals, including
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.